Mouse Tmem135 mutation reveals a mechanism involving mitochondrial dynamics that leads to age-dependent retinal pathologies

  1. Wei-Hua Lee
  2. Hitoshi Higuchi
  3. Sakae Ikeda
  4. Erica L Macke
  5. Tetsuya Takimoto
  6. Bikash R Pattnaik
  7. Che Liu
  8. Li-Fang Chu
  9. Sandra M Siepka
  10. Kathleen J Krentz
  11. C Dustin Rubinstein
  12. Robert F Kalejta
  13. James A Thomson
  14. Robert F Mullins
  15. Joseph S Takahashi
  16. Lawrence Pinto
  17. Akihiro Ikeda  Is a corresponding author
  1. University of Wisconsin-Madison, United States
  2. Okayama University Hospital, Japan
  3. Morgridge Institute for Research, United States
  4. Northwestern University, United States
  5. University of Iowa, United States
  6. Howard Hughes Medical Institute, University of Texas Southwestern Medical Center, United States

Abstract

While aging process is central to the pathogenesis of age-dependent diseases, it is poorly understood at the molecular level. We identified a mouse mutant with accelerated aging in the retina as well as pathologies observed in age-dependent retinal diseases, suggesting that the responsible gene regulates retinal aging, and its impairment results in age-dependent disease. We determined that a mutation in the transmembrane 135 (Tmem135) is responsible for these phenotypes. We observed localization of TMEM135 on mitochondria, and imbalance of mitochondrial fission and fusion in mutant Tmem135 as well as Tmem135 overexpressing cells, indicating that TMEM135 is involved in the regulation of mitochondrial dynamics. Additionally, mutant retina showed higher sensitivity to oxidative stress. These results suggest that the regulation of mitochondrial dynamics through TMEM135 is critical for protection from environmental stress and controlling the progression of retinal aging. Our study identified TMEM135 as a critical link between aging and age-dependent diseases.

Article and author information

Author details

  1. Wei-Hua Lee

    Department of Medical Genetics, University of Wisconsin-Madison, Madison, United States
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-8032-0279
  2. Hitoshi Higuchi

    Department of Dental Anesthesiology, Okayama University Hospital, Okayama, Japan
    Competing interests
    No competing interests declared.
  3. Sakae Ikeda

    Department of Medical Genetics, University of Wisconsin-Madison, Madison, United States
    Competing interests
    No competing interests declared.
  4. Erica L Macke

    Department of Medical Genetics, University of Wisconsin-Madison, Madison, United States
    Competing interests
    No competing interests declared.
  5. Tetsuya Takimoto

    Department of Medical Genetics, University of Wisconsin-Madison, Madison, United States
    Competing interests
    No competing interests declared.
  6. Bikash R Pattnaik

    McPherson Eye Research Institute, University of Wisconsin-Madison, Madison, United States
    Competing interests
    No competing interests declared.
  7. Che Liu

    Institute for Molecular Virology, University of Wisconsin-Madison, Madison, United States
    Competing interests
    No competing interests declared.
  8. Li-Fang Chu

    Morgridge Institute for Research, Madison, United States
    Competing interests
    No competing interests declared.
  9. Sandra M Siepka

    The Chemistry of Life Processes Institute, Northwestern University, Evanston, United States
    Competing interests
    No competing interests declared.
  10. Kathleen J Krentz

    Transgenic Mouse Facility, Biotechnology Center, University of Wisconsin-Madison, Madison, United States
    Competing interests
    No competing interests declared.
  11. C Dustin Rubinstein

    Translational Genomics Facility, Biotechnology Center, University of Wisconsin-Madison, Madison, United States
    Competing interests
    No competing interests declared.
  12. Robert F Kalejta

    Institute for Molecular Virology, University of Wisconsin-Madison, Madison, United States
    Competing interests
    No competing interests declared.
  13. James A Thomson

    Morgridge Institute for Research, Madison, United States
    Competing interests
    No competing interests declared.
  14. Robert F Mullins

    Department of Ophthalmology and Visual, University of Iowa, Iowa City, United States
    Competing interests
    No competing interests declared.
  15. Joseph S Takahashi

    Department of Neuroscience, Howard Hughes Medical Institute, University of Texas Southwestern Medical Center, Dallas, United States
    Competing interests
    Joseph S Takahashi, Reviewing editor, eLife.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-0384-8878
  16. Lawrence Pinto

    Department of Neurobiology, Northwestern University, Evanston, United States
    Competing interests
    No competing interests declared.
  17. Akihiro Ikeda

    Department of Medical Genetics, University of Wisconsin-Madison, Madison, United States
    For correspondence
    aikeda@wisc.edu
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-8440-3891

Funding

National Institutes of Health (R21 EY023061, R01 EY022086)

  • Akihiro Ikeda

Retina Research Foundation (Professorship)

  • Akihiro Ikeda

Howard Hughes Medical Institute

  • Joseph S Takahashi

National Institutes of Health (U01 MH61915)

  • Joseph S Takahashi

National Institutes of Health (P30 845 EY016665, P30 HD003352)

  • Akihiro Ikeda

National Institutes of Health (T32 GM007133)

  • Erica L Macke

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Reviewing Editor

  1. Jeremy Nathans, Johns Hopkins University School of Medicine, United States

Ethics

Animal experimentation: All experiments were performed in accordance with the National Institute of Health Guide for the Care and Use of Laboratory Animals and were approved by the Animal Care and Use Committee (IACUC) protocols (M01771) at the University of Wisconsin-Madison.

Version history

  1. Received: July 1, 2016
  2. Accepted: October 25, 2016
  3. Accepted Manuscript published: November 15, 2016 (version 1)
  4. Version of Record published: November 21, 2016 (version 2)

Copyright

© 2016, Lee et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 3,813
    views
  • 555
    downloads
  • 40
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Wei-Hua Lee
  2. Hitoshi Higuchi
  3. Sakae Ikeda
  4. Erica L Macke
  5. Tetsuya Takimoto
  6. Bikash R Pattnaik
  7. Che Liu
  8. Li-Fang Chu
  9. Sandra M Siepka
  10. Kathleen J Krentz
  11. C Dustin Rubinstein
  12. Robert F Kalejta
  13. James A Thomson
  14. Robert F Mullins
  15. Joseph S Takahashi
  16. Lawrence Pinto
  17. Akihiro Ikeda
(2016)
Mouse Tmem135 mutation reveals a mechanism involving mitochondrial dynamics that leads to age-dependent retinal pathologies
eLife 5:e19264.
https://doi.org/10.7554/eLife.19264

Share this article

https://doi.org/10.7554/eLife.19264

Further reading

    1. Cell Biology
    2. Stem Cells and Regenerative Medicine
    Rajdeep Banerjee, Thomas J Meyer ... David D Roberts
    Research Article

    Extramedullary erythropoiesis is not expected in healthy adult mice, but erythropoietic gene expression was elevated in lineage-depleted spleen cells from Cd47−/− mice. Expression of several genes associated with early stages of erythropoiesis was elevated in mice lacking CD47 or its signaling ligand thrombospondin-1, consistent with previous evidence that this signaling pathway inhibits expression of multipotent stem cell transcription factors in spleen. In contrast, cells expressing markers of committed erythroid progenitors were more abundant in Cd47−/− spleens but significantly depleted in Thbs1−/− spleens. Single-cell transcriptome and flow cytometry analyses indicated that loss of CD47 is associated with accumulation and increased proliferation in spleen of Ter119CD34+ progenitors and Ter119+CD34 committed erythroid progenitors with elevated mRNA expression of Kit, Ermap, and Tfrc. Induction of committed erythroid precursors is consistent with the known function of CD47 to limit the phagocytic removal of aged erythrocytes. Conversely, loss of thrombospondin-1 delays the turnover of aged red blood cells, which may account for the suppression of committed erythroid precursors in Thbs1−/− spleens relative to basal levels in wild-type mice. In addition to defining a role for CD47 to limit extramedullary erythropoiesis, these studies reveal a thrombospondin-1-dependent basal level of extramedullary erythropoiesis in adult mouse spleen.

    1. Cell Biology
    Makiko Kashio, Sandra Derouiche ... Makoto Tominaga
    Research Article

    Reports indicate that an interaction between TRPV4 and anoctamin 1 (ANO1) could be widely involved in water efflux of exocrine glands, suggesting that the interaction could play a role in perspiration. In secretory cells of sweat glands present in mouse foot pads, TRPV4 clearly colocalized with cytokeratin 8, ANO1, and aquaporin-5 (AQP5). Mouse sweat glands showed TRPV4-dependent cytosolic Ca2+ increases that were inhibited by menthol. Acetylcholine-stimulated sweating in foot pads was temperature-dependent in wild-type, but not in TRPV4-deficient mice and was inhibited by menthol both in wild-type and TRPM8KO mice. The basal sweating without acetylcholine stimulation was inhibited by an ANO1 inhibitor. Sweating could be important for maintaining friction forces in mouse foot pads, and this possibility is supported by the finding that wild-type mice climbed up a slippery slope more easily than TRPV4-deficient mice. Furthermore, TRPV4 expression was significantly higher in controls and normohidrotic skin from patients with acquired idiopathic generalized anhidrosis (AIGA) compared to anhidrotic skin from patients with AIGA. Collectively, TRPV4 is likely involved in temperature-dependent perspiration via interactions with ANO1, and TRPV4 itself or the TRPV4/ANO 1 complex would be targeted to develop agents that regulate perspiration.